We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARTX
7026
DELISTED
Arotech Corporation
ARTX
$178K ﹤0.01%
50,115
+28,526
+132% +$110K
MNTA
7027
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$177K ﹤0.01%
+12,700
New +$172K
CLNE icon
7028
PUT
Clean Energy Fuels
CLNE
$403M
$176K ﹤0.01%
86,900
+6,000
+7% +$13.3K
FTK icon
7029
PUT
Flotek Industries
FTK
$1.3B
$176K ﹤0.01%
6,300
+4,050
+180% +$115K
QMCO icon
7030
Quantum Corp
QMCO
$1.03B
$176K ﹤0.01%
1,564
+595
+61% +$64K
LABD icon
7031
PUT
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
$175K ﹤0.01%
19
-2
-10% -$19.9K
RDI icon
7032
CALL
Reading International Class A
RDI
$36.6M
$175K ﹤0.01%
+10,500
New +$165K
GIG.U
7033
DELISTED
GigCapital, Inc.
GIG.U
$175K ﹤0.01%
+17,488
New +$175K
ASX icon
7034
ASE Group
ASX
$103B
$174K ﹤0.01%
26,877
-29,823
-53% -$189K
NWG icon
7035
NatWest
NWG
$76B
$174K ﹤0.01%
21,169
+8,587
+68% +$68.6K
IHIT
7036
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$174K ﹤0.01%
+17,779
New +$178K
WMC
7037
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$174K ﹤0.01%
1,746
-5,464
-76% -$556K
GCI
7038
CALL
DELISTED
Gannett Co., Inc
GCI
$174K ﹤0.01%
+15,000
New +$157K
SMHI icon
7039
SEACOR Marine Holdings
SMHI
$268M
$173K ﹤0.01%
14,756
-1,714
-10% -$22.6K
ACHN
7040
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$173K ﹤0.01%
60,100
+1,100
+2% +$4K
ITCI
7041
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$172K ﹤0.01%
11,900
-3,300
-22% -$51K
BOOT icon
7042
PUT
Boot Barn
BOOT
$4.95B
$171K ﹤0.01%
+10,300
New +$123K
CSTM icon
7043
CALL
Constellium
CSTM
$4.01B
$171K ﹤0.01%
+15,300
New +$163K
CTLP
7044
CALL
DELISTED
Cantaloupe
CTLP
$171K ﹤0.01%
17,500
-4,800
-22% -$36.8K
ERF
7045
PUT
DELISTED
Enerplus Corporation
ERF
$171K ﹤0.01%
+17,500
New +$160K
TTPH
7046
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$171K ﹤0.01%
+1,358
New +$174K
SDRL
7047
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
$171K ﹤0.01%
2,767
+456
+20% +$36.4K
BOJA
7048
CALL
DELISTED
Bojangles', Inc. Common Stock
BOJA
$171K ﹤0.01%
14,500
+800
+6% +$10.1K
RDHL
7049
Redhill Biopharma
RDHL
$3.65M
$170K ﹤0.01%
+33
New +$222K
LBY
7050
DELISTED
Libbey, Inc.
LBY
$170K ﹤0.01%
22,587
-122,000
-84% -$953K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.